Is a realignment imminent

[anonymous]

LTC isn’t adding as much value as expected, by end of year the Neurology team will only promote ingrezza. We don’t need 3 teams to promote 1 product.

 

[anonymous]

LTC isn’t adding as much value as expected, by end of year the Neurology team will only promote ingrezza. We don’t need 3 teams to promote 1 product.

That is what I'm hearing from a very reliable source.

 

[anonymous]

LTC likely first to go. Huge salaries and low results. Ingrezza much better for younger patients anyways. Mistake!

 

[anonymous]

With no skin in this .......it sounds like one of the other teams are threatened? LTC is being targeted

 

[anonymous]

With no skin in this .......it sounds like one of the other teams are threatened? LTC is being targeted

That’s an interesting perspective! What makes you feel like the LTC team is being targeted?